Abstract: Antibodies against a virus can be detected in a sample using at least one reagent comprising at least one capture molecule immobilized to a particle, which reagent in the presence of such antibodies forms an anti-virus antibody-capture molecule complex, wherein the presence of said complex is qualitatively, quantitatively or semi-quantitatively determined by measuring a signal generated by said complex, said particle is a nanoparticle and said capture molecule is immobilized to said nanoparticle simultaneously with a co-molecule which is smaller than said capture molecule. When the capture molecule is a virus epitope, the co-molecule preferably has a molecular weight in the range of 50-1500 Da, wherein said co-molecules when immobilized on said nanoparticle separate the capture molecules so that an average distance between two adjacent capture molecules is greater than a distance between the antigen binding sites of the anti-virus antibody to be detected.

Abstract: The precision of a lateral flow assay for determining the concentration of an analyte in the plasma fraction of a sample of whole blood can be significantly improved by applying an integrated step for determining the hematocrit of the optionally diluted sample, and taking both hematocrit and dilution factor into account when calculating the concentration of the analyte. This is made possible inter alia by using a predetermined wavelength when taking an image of the sample after application to a substrate in the lateral flow assay device, and wherein said wavelength is selected based on the dilution factor used. This hematocrit measurement is advantageously integrated in lateral flow assay methods and devices for the measurement of an analyte in plasma and contributes significantly to an improved precision of such assays.

Abstract: A hematocrit level in a sample of whole blood can be determined in a lateral flow assay setting, where a sample of whole blood is applied to a substrate on which a blood spot is formed; taking an image of said blood spot within 1-300 seconds from application, subjecting said image to image analysis, and determining the hematocrit level based on a value of at least one parameter extracted from said image. Such reagent-free hematocrit measurement can be integrated in lateral flow assay devices for the measurement of an analyte and contribute to significantly improved precision of such assays.

Abstract: A dried adhesive coating is manufactured by steps of: a) providing a composition comprising a solution of a polymer, wherein at least 1 wt % of said polymer based on the molecular weight Mw are catechol groups, and wherein the concentration of said polymer in said composition is from 0.1 to 250 mg/ml, b) adjusting the pH of the composition to a value from about ó to about 7, either (i) before applying the composition to the surface to be coated or (ii) after applying the composition to the surface to be coated, c) applying the composition to the surface to be coated to obtain an adhesive coating on at least a part of the surface, and d) drying the coating.

Abstract: A dried adhesive coating is manufactured by steps of: a) providing a composition comprising a solution of a polymer, wherein at least 1 wt % of said polymer based on the molecular weight Mw are catechol groups, and wherein the concentration of said polymer in said composition is from 0.1 to 250 mg/ml, b) adjusting the pH of the composition to a value from about ó to about 7, either (i) before applying the composition to the surface to be coated or (ii) after applying the composition to the surface to be coated, c) applying the composition to the surface to be coated to obtain an adhesive coating on at least a part of the surface, and d) drying the coating.

Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.

Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.

Abstract: The invention herein relates to the method and use in an antifouling paint that specifically and efficiently impede settlement of for example barnacles on aquatic structures, using imidazole containing compound, such as Medetomidine, bound to a sulfonated, acid sulphate ester, phosphonic acid, carboxylic acid or acid phosphate ester modified polymer backbone such as polystyrene or acrylate polymers. The aim is to employ the biocide-polymer complexes as additives in a self-polishing paint for controlled release purposes.

Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.

Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.

Abstract: The invention herein relates to the method and use in an antifouling paint that specifically and efficiently impede settlement of for example barnacles on aquatic structures, using imidazole containing compound, such as Medetomidine, bound to a sulfonated, acid sulphate ester, phosphonic acid, carboxylic acid or acid phosphate ester modified polymer backbone such as polystyrene or acrylate polymers. The aim is to employ the biocide-polymer complexes as additives in a self-polishing paint for controlled release purposes.

Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.